Navigation Links
Landmark Findings From ECLIPSE Program Show Improved Control of,Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery

Largest Randomized Safety Program of Intravenous Antihypertensives to Date Presented at ACC Scientific Sessions

NEW ORLEANS, March 27, 2007 /PRNewswire-FirstCall/ -- Findings from ECLIPSE**, the largest safety program comparing intravenous antihypertensive therapies, show that improved control of perioperative hypertension -- a potentially harmful elevation in blood pressure just before, during and/or after surgery - - in patients undergoing cardiac surgery is strongly associated with a reduced risk of death within 30 days following the procedure. The findings were presented at a late-breaking session here at the 56th Annual Scientific Session of the of Cardiology (ACC).

"Perioperative hypertension is a very common problem in cardiac surgery, affecting up to 80 percent of patients," said lead author of the presentation, Solomon Aronson, MD, Duke University Medical Center**. "Findings from ECLIPSE are the first to quantify the relationship between perioperative blood pressure control and clinical outcomes, and demonstrate that better control can dramatically reduce the rate of death in cardiac surgery patients."

"This ECLIPSE analysis contributes to advances in the understanding and treatment of acute hypertension, a condition which affects nearly 3 million people in the U.S. each year," said John Kelley, President and Chief Operating Officer of The Medicines Company. "The Medicines Company is committed to further understanding the importance of better blood pressure control in the acute care setting and we strive to help improve the outcomes of patients who face this life-threatening condition."

Study and Findings

The ECLIPSE program included a total of 1,964 cardiac surgery patients each enrolled in one of three randomized, open-label trials comparing Cleviprex(TM) (clevidipine) to current intravenous antihypertensive agents: nitroglycerin, sodium nitroprusside or nicardipine. Begin
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
2. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
3. Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07 Teleconference to Answer Questions About TA-65, Their Telomerase Activator With Proven Age Management Benefits
4. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
5. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
6. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Molecular Target of Bradmers Neuradiab Further Validated by Independent Findings
10. Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science
11. Advanced Viral Research Corp. Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study
Post Your Comments:
(Date:4/1/2015)... , April 1, 2015  Salix Pharmaceuticals, Ltd. ... International, Inc. (NYSE: VRX ) (TSX:VRX), today ... outstanding $750,000,000 aggregate principal amount of its 6.00% ... (the " Notes ") pursuant to two redemptions. ... aggregate principal amount of the Notes, and on ...
(Date:4/1/2015)... 2015  Daiichi Sankyo, Inc., the US subsidiary of ... merge with its US-based sister company, Asubio Pharmaceuticals, Inc.  ... integrated into the Daiichi Sankyo global development organization, led ... Asubio Pharmaceuticals, parent company, Asubio Pharma Co., Ltd, ... will continue to operate as a wholly owned subsidiary ...
(Date:4/1/2015)... , April 1, 2015 Valeant Pharmaceuticals International, ... today announced the expiration of the tender offer (the ... to purchase all of the outstanding shares of Salix ... price of $173.00 per share in cash, without interest, ... midnight, Eastern time, on April 1, 2015.  Valeant expects ...
Breaking Medicine Technology:Redemption of All of Salix's Outstanding 6.00% Senior Notes due 2021 2Redemption of All of Salix's Outstanding 6.00% Senior Notes due 2021 3Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge 2Valeant Pharmaceuticals International, Inc. Completes Tender Offer For Salix Pharmaceuticals, Ltd. 2Valeant Pharmaceuticals International, Inc. Completes Tender Offer For Salix Pharmaceuticals, Ltd. 3
(Date:4/1/2015)... 2015 BioPlus Specialty Pharmacy ... has released a new app to keep health care ... chronic hepatitis C virus (HCV) infection. This ‘HCV Treatment ... from the American Association for the Study of Liver ... new direct-acting oral medications to treat HCV have been ...
(Date:4/1/2015)... Dr. Daniel C. Stewart will be ... the benefits of the LANAP® treatment over traditional ... People who live in Howard County, and surrounding areas ... visit Dr. Stewart, a Maryland dentist, for a minimally ... protocol, which is a laser gum surgery procedure, Dr. ...
(Date:4/1/2015)... 2015 OSF Saint Paul Medical Center, ... , was welcomed into the Ministry April 1, 2015, ... Paul E. Showalter, vicar general of the Catholic Diocese ... culminated a nearly year-long transition process for the former ... Speakers for the morning ceremony included Sister Judith Ann ...
(Date:4/1/2015)... 2015 Aging2.0 , the global ... the launch of the Aging2.0 Alliance – ... and technology companies. The announcement was made today at ... Business Strategies Forum in San Diego, CA. ... program is now open for additional members. “This is ...
(Date:4/1/2015)... April 01, 2015 Dr. Rod ... Distinguished Teaching Professor of the Department of Plastic Surgery ... doctors to review reports of blindness resulting from the ... . The group published their study, along with ideas ... Surgery journal. , "We began to see increasing reports ...
Breaking Medicine News(10 mins):Health News:BioPlus Specialty Pharmacy Releases ‘HCV Treatment Path’ App for Hepatitis C Providers 2Health News:Dr. Daniel C. Stewart Offers Columbia Area Residents an Informational Seminar in April About Less Invasive Gum Disease Treatment Now Available at Smile Savers Dentistry 2Health News:Dr. Daniel C. Stewart Offers Columbia Area Residents an Informational Seminar in April About Less Invasive Gum Disease Treatment Now Available at Smile Savers Dentistry 3Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 2Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 3Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 2Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 3Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 4Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 2Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 3
... Eldik, director of the University of Kentucky Sanders-Brown Center on ... research into a possible treatment for Alzheimer,s disease. The grant ... Foundation, and was one of only eight Awards in Alzheimer,s ... in 2010. Van Eldik,s research project focuses on developing ...
... MONDAY, Jan. 24 (HealthDay News) -- The anti-estrogen drug that ... also reduce the risk of dying from lung cancer, researchers ... online edition of the journal Cancer , tamoxifen lowered ... already had breast cancer. However, the results are too ...
... This release is available in French . ... Timothy Geary received a $1-million grant today for landmark ... African biodiversity. Grand Challenges Canada, Canada,s International Development ... the Bill & Melinda Gates Foundation have joined together ...
... Reinberg HealthDay Reporter , SUNDAY, Jan. 23 (HealthDay ... may be delayed until the end of this week because ... said Saturday. Dr. John Holcomb, a trauma surgeon and ... have to decide whether a catheter draining the fluid can ...
... -- By this point, New Year,s resolutions might be a ... fine-tuning, especially for those who resolved to lose weight. ... Denver, suggests using what she calls the "SMART" system to ... for goals that are specific, measurable, attainable, realistic and timely. ...
... deciphered the genetic code for a type of pancreatic cancer, ... in the Jan. 20 issue of Science Express, ... twice as long as those without them. "One of ... with this kind of rare cancer has a unique genetic ...
Cached Medicine News:Health News:Breast Cancer Drug May Also Help Lung Cancer Patients 2Health News:McGill awarded $1-million grant to address debilitating parasitic diseases in the developing world 2Health News:McGill awarded $1-million grant to address debilitating parasitic diseases in the developing world 3Health News:Rep. Giffords Set to Begin Rehab in Houston 2Health News:Rep. Giffords Set to Begin Rehab in Houston 3Health News:Rep. Giffords Set to Begin Rehab in Houston 4Health News:How to Get Smart About Weight Loss 2Health News:Johns Hopkins scientists crack genetic code for form of pancreatic cancer 2Health News:Johns Hopkins scientists crack genetic code for form of pancreatic cancer 3
Provides quick access to information needed to make diagnoses and treatment decisions....
PDA format of the well-known standard antimicrobial reference....
PDA application containing all 7,000+ Physicians' Current Procedural Terminology codes developed by the American Medical Association....
PDA application providing a complete guide for the diagnosis and management of electrolyte disorders....
Medicine Products: